Awards
2022
Top Rankings in Five Categories
including Honored Companies, etc.
Institutional Investor
2021
Executive of the Year
Scrip Awards
2020
50 Smartest Companies
MIT Technology Review
2019
Top 10 Immuno-Oncology Startups
GEN
I-Mab is a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer.
2022
Top Rankings in Five Categories
including Honored Companies, etc.
Institutional Investor
2021
Executive of the Year
Scrip Awards
2020
50 Smartest Companies
MIT Technology Review
2019
Top 10 Immuno-Oncology Startups
GEN